Polymorphisms in OATP-C: identification of multiple allelic variants associated with altered transport activity among European- and African-Americans
- PMID: 11477075
- DOI: 10.1074/jbc.M103792200
Polymorphisms in OATP-C: identification of multiple allelic variants associated with altered transport activity among European- and African-Americans
Abstract
The human organic anion transporting polypeptide-C (OATP-C) (gene SLC21A6) is a liver-specific transporter importantly involved in the hepatocellular uptake of a variety of endogenous and foreign chemicals. In this study, we demonstrate the presence of multiple functionally relevant single-nucleotide polymorphisms (SNPs) in OATP-C in a population of African- and European-Americans. Moreover, examination of 14 nonsynonymous polymorphisms indicated that genotypic frequencies were dependent on race. Functional assessment of 16 OATP-C alleles in vitro revealed that several variants exhibited markedly reduced uptake of the OATP-C substrates estrone sulfate and estradiol 17beta-d-glucuronide. Specifically, alterations in transport were associated with SNPs that introduce amino acid changes within the transmembrane-spanning domains (T217C (Phe-73 --> Leu), T245C (Val-82 --> Ala), T521C (Val-174 --> Ala), and T1058C (Ile-353 --> Thr)) and also with those that modify extracellular loop 5 (A1294G (Asn-432 --> Asp), A1385G (Asp-462 --> Gly), and A1463C (Gly-488 --> Ala)). Cell surface biotinylation experiments indicated that the altered transport activity of some OATP-C variants was due, in part, to decreased plasma membrane expression. Given the relatively high genotypic frequency of the T521C (14%) transition in European-Americans and the G1463C (9%) transversion in African-Americans, SNPs in OATP-C may represent a heretofore unrecognized factor influencing drug disposition.
Similar articles
-
Ethnicity-dependent polymorphism in Na+-taurocholate cotransporting polypeptide (SLC10A1) reveals a domain critical for bile acid substrate recognition.J Biol Chem. 2004 Feb 20;279(8):7213-22. doi: 10.1074/jbc.M305782200. Epub 2003 Dec 2. J Biol Chem. 2004. PMID: 14660639
-
Identification of functionally variant MDR1 alleles among European Americans and African Americans.Clin Pharmacol Ther. 2001 Aug;70(2):189-99. doi: 10.1067/mcp.2001.117412. Clin Pharmacol Ther. 2001. PMID: 11503014
-
Polymorphisms of OATP-C (SLC21A6) and OAT3 (SLC22A8) genes: consequences for pravastatin pharmacokinetics.Clin Pharmacol Ther. 2003 Jun;73(6):554-65. doi: 10.1016/S0009-9236(03)00060-2. Clin Pharmacol Ther. 2003. PMID: 12811365
-
Genetic contribution to variable human CYP3A-mediated metabolism.Adv Drug Deliv Rev. 2002 Nov 18;54(10):1271-94. doi: 10.1016/s0169-409x(02)00066-2. Adv Drug Deliv Rev. 2002. PMID: 12406645 Review.
-
Genetics or environment in drug transport: the case of organic anion transporting polypeptides and adverse drug reactions.Expert Opin Drug Metab Toxicol. 2012 Mar;8(3):349-60. doi: 10.1517/17425255.2012.656087. Epub 2012 Jan 27. Expert Opin Drug Metab Toxicol. 2012. PMID: 22280100 Free PMC article. Review.
Cited by
-
Effect of CYP2C9 and SLCO1B1 polymorphisms on the pharmacokinetics and pharmacodynamics of nateglinide in healthy Chinese male volunteers.Eur J Clin Pharmacol. 2013 Mar;69(3):407-13. doi: 10.1007/s00228-012-1364-9. Epub 2012 Jul 28. Eur J Clin Pharmacol. 2013. PMID: 22842957 Clinical Trial.
-
Pharmacogenomics of drug metabolizing enzymes and transporters: implications for cancer therapy.Pharmgenomics Pers Med. 2011;4:11-33. doi: 10.2147/PGPM.S18861. Epub 2011 Apr 1. Pharmgenomics Pers Med. 2011. PMID: 23226051 Free PMC article.
-
Impact of ABCG2 and SLCO1B1 polymorphisms on pharmacokinetics of rosuvastatin, atorvastatin and simvastatin acid in Caucasian and Asian subjects: a class effect?Eur J Clin Pharmacol. 2015 Mar;71(3):341-55. doi: 10.1007/s00228-014-1801-z. Epub 2015 Feb 12. Eur J Clin Pharmacol. 2015. PMID: 25673568 Clinical Trial.
-
Direct and rapid genotyping of SLCO1B1 388A>G and 521T>C in human blood specimens using the SmartAmp-2 method.AAPS J. 2013 Apr;15(2):618-22. doi: 10.1208/s12248-013-9471-9. Epub 2013 Mar 8. AAPS J. 2013. PMID: 23471819 Free PMC article.
-
The farnesoid X receptor -1G>T polymorphism influences the lipid response to rosuvastatin.J Lipid Res. 2012 Jul;53(7):1384-9. doi: 10.1194/jlr.M026054. Epub 2012 Apr 24. J Lipid Res. 2012. PMID: 22534644 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases